Healthcare
Recent Sell-Off in Jounce therapeutics’ (JNCE) Stock Is Unwarranted
Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO …
Omeros (OMER) Stock Could Become a 10-Bagger
By Richard Robinson Many Americans are optimistic about achieving a comfortable retirement. They fund their 401(k) …
Hedge Fund Tycoon David Shaw Makes 2 Risky Bio Bets: MannKind Corporation (MNKD), Valeant Pharmaceuticals Intl Inc (VRX)
Chief scientist Shaw looks for unusual sources of return in MNKD and VRX.
Can Synergy Pharmaceuticals Inc Get Things Moving Again with Trulance?
Wednesday could mark a turning point for Synergy investors.
4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE)
Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a …
A Growing Medical Device Player Aiming to Rule the $6.3 Billion Pain Market; An Exclusive Interview with Zynex CEO Thomas Sandgaard
Before founding Zynex, Inc. (OTCMKTS:ZYXI) over two decades ago, Thomas Sandgaard was a man who …
Does Teva Pharmaceutical Industries Ltd (ADR) (TEVA) CEO Schultz Need a Bodyguard?
Is Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) “a ticking bomb” after new Danish CEO Kare …
Quant Fund Gurus John Overdeck And David Siegel Throw the Towel on Valeant Pharmaceuticals Intl Inc (VRX), Pull the Trigger on Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
This 50 billion-dollar fund is dropping VRX and turning to TEVA.
Joel Greenblatt’s Magic Formula Says No to Two Pharma Giants: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD)
Why this Wall Street hedge fund legend sold VRX and GILD?
Ex-Harvard Endowment Bosses Make Surprise Bet on Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Say Goodbye to Valeant Pharmaceuticals Intl Inc (VRX)
This billion-dollar hedge fund initiates new position in struggling pharma TEVA as exits VRX.